Carta Acesso aberto Revisado por pares

Melanoma With Second Myxoid Stromal Changes After Personally Applied Prolonged Phototherapy

2009; Lippincott Williams & Wilkins; Volume: 31; Issue: 7 Linguagem: Inglês

10.1097/dad.0b013e3181b7f6ca

ISSN

1533-0311

Autores

Vranic Sanja,

Tópico(s)

Cutaneous Melanoma Detection and Management

Resumo

To the Editor: The article, “Melanoma With Second Myxoid Stromal Changes After Personally Applied Prolonged Phototherapy,” reports that a patient who used a Bioptron phototherapy lamp to treat a cancerous skin lesion without a doctor's advice, and who delayed seeking medical treatment, succumbed to advanced primary cutaneous melanoma. No scientific evidence or clinical data exist to support any suggestion or inference that Bioptron therapy caused or contributed to the patient's cancer and death. Bioptron light therapy has become widely accepted as a new form of treatment in prevention, therapy, and rehabilitation worldwide, and can improve microcirculation, harmonize metabolic processes, reinforce the human defense system, stimulate regenerative and reparative processes of the entire organism, promote wound healing, and relieve pain or decrease its intensity. The medical indications of the Bioptron light therapy are clearly defined in the “Medical Indications” booklet, and as recommended in the operating instructions, patients should consult with a physician before using Bioptron light therapy. Dr. Sanja Vranic BIOPTRON AG, Wollerau, Switzerland

Referência(s)